ZEB1 and neoplasm: Approaches aimed at disrupting epithelial-mesenchymal transition (EMT) and reversing stemness-associated traits, particularly through inhibition of key transcriptional regulators such as SNAIL, ZEB, and TWIST, have gained traction for their potential to reduce tumor aggressiveness and therapy resistance 36.